Cargando…
The (Poly)phenol-Carbohydrate Combination for Diabetes: Where Do We Stand?
The type 2 diabetes epidemic is real and hardly coming to an end in the upcoming years. The efforts of the scientific community to develop safer and more effective compounds for type 2 diabetes based on the structure of natural (poly)phenols are remarkable and have indeed proven worthwhile after the...
Autores principales: | de Matos, Ana Marta, Menezes, Regina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965656/ https://www.ncbi.nlm.nih.gov/pubmed/36839354 http://dx.doi.org/10.3390/nu15040996 |
Ejemplares similares
-
Ion Channels and Transporters in Immunity—Where do We Stand?
por: Hoeger, Birgit, et al.
Publicado: (2022) -
Ablative Management of Persistent Atrial Fibrillation (PeAF) with Posterior Wall Isolation (PWI): Where Do We Stand?
por: Baqal, Omar, et al.
Publicado: (2023) -
Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand?
por: Chancharoenthana, Wiwat, et al.
Publicado: (2019) -
Vaccine for Diabetes—Where Do We Stand?
por: Chellappan, Dinesh Kumar, et al.
Publicado: (2022) -
Where Do We Stand?
Publicado: (1891)